Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs

Journal of Human Genetics

Volumn 55, Issue 2, 2010, Pages 121-123

  Jung, Yoon Suk ^a   Cheon, Jae Hee ^a   Park, Jae Jun ^a   Moon, Chang Mo ^a   Kim, Eun Soo ^a   Lee, Jin Ha ^a   Kim, Seung Won ^a   Kim, Jae Hak ^b   Hong, Sung Pil ^a   Kim, Tae Il ^a   Kim, Won Ho ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Azathioprine; Inflammatory bowel disease; Inosine triphosphate pyrophosphatase; Relapse; Thiopurine S methyl transferase

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; THIOPURINE METHYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENTERITIS; FEMALE; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; REMISSION; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ASIAN CONTINENTAL ANCESTRY GROUP; AZATHIOPRINE; GENE FREQUENCY; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; METHYLTRANSFERASES; PYROPHOSPHATASES; RECURRENCE; TREATMENT OUTCOME;

EID: 77649144586     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2009.125     Document Type: Article

References (18)

1. Present, D. H., Korelitz, B. I., Wisch, N., Glass, J. L., Sachar, D. B. & Pasternack, B. S. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N. Engl. J. Med. 302, 981-987 (1980).
2. Candy, S., Wright, J., Gerber, M., Adams, G., Gerig, M. & Goodman, R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 37, 674-678 (1995).
3. Black, A. J., McLeod, H. L., Capell, H. A., Powrie, R. H., Matowe, L. K., Pritchard, S. C. et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann. Intern. Med. 129, 716-718 (1998).
4. Cuffari, C., Dassopoulos, T., Turnbough, L., Thompson, R. E. & Bayless, T. M. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 2, 410-417 (2004).
5. Zelinkova, Z., Derijks, L. J., Stokkers, P. C., Vogels, E. W., van Kampen, A. H., Curvers, W. L. et al. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Clin. Gastroenterol. Hepatol. 4, 44-49 (2006).
6. Marinaki, A. M., Ansari, A., Duley, J. A., Arenas, M., Sumi, S., Lewis, C. M. et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 14, 181-187 (2004).
7. Sandborn, W. J., Feagan, B. G., Hanauer, S. B., Lochs, H., Löfberg, R., Modigliani, R. et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 122, 512-530 (2002).
8. Lewis, J. D., Chuai, S., Nessel, L., Lichtenstein, G. R., Aberra, F. N. & Ellenberg, J. H. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm. Bowel Dis. 14, 1660-1666 (2008).
9. Kim, J. S., Lim, S. H., Choi, I. J., Moon, H., Jung, H. C., Song, I. S. et al. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. Endoscopy 32, 635-640 (2000).
10. Schaeffeler, E., Lang, T., Zanger, U. M., Eichelbaum, M. & Schwab, M. High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC. Clin. Chem. 47, 548-555 (2001).
11. Sasaki, T., Goto, E., Konno, Y., Hiratsuka, M. & Mizugaki, M. Three novel single nucleotide polymorphisms of the human thiopurine S-methyltransferase gene in Japanese individuals. Drug Metab. Pharmacokinet. 21, 332-336 (2006).
12. Jun, J. B., Cho, D. Y., Kang, C. & Bae, S. C. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine. Clin. Exp. Rheumatol. 23, 873-876 (2005).
13. Kim, J. H., Cheon, J. H. & Kim, W. H. [The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease]. Korean J. Gastroenterol. (Taehan Sohwagi Hakhoe chi) 51, 291-297 (2008).
14. Collie-Duguid, E. S., Pritchard, S. C., Powrie, R. H., Sludden, J., Collier, D. A., Li, T. et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 9, 37-42 (1999).
15. Ansari, A., Hassan, C., Duley, J., Marinaki, A., Shobowale-Bakre, E. M., Seed, P. et al. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment. Pharmacol. Ther. 16, 1743-1750 (2002).
16. Ansari, A., Arenas, M., Greenfield, S. M., Morris, D., Lindsay, J., Gilshenan, K. et al. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease. Aliment. Pharmacol. Ther. 28, 973-983 (2008).
17. Cao, H. & Hegele, R. A. DNA polymorphisms in ITPA including basis of inosine triphosphatase deficiency. J. Hum. Genet. 47, 620-622 (2002).
18. Marinaki, A. M., Sumi, S., Arenas, M., Fairbanks, L., Harihara, S., Shimizu, K. et al. Allele frequency of inosine triphosphate pyrophosphatase gene polymorphisms in a Japanese population. Nucleosides Nucleotides Nucleic Acids 23, 1399-1401 (2004).